What is the current price of 2228.HK stock and its immediate outlook?

2228.HK stock closed at **HK$11.25** on 16 Feb 2026. Near-term outlook is mixed; technicals show limited momentum while forecasts range from **HK$10.73** to **HK$13.19** depending on the horizon.

How does Meyka AI rate 2228.HK stock and what does the grade mean?

Meyka AI rates 2228.HK with a **62.99** score (Grade B, HOLD). The grade weighs benchmark comparison, sector trends, financial metrics, forecasts, and analyst views. This is informational, not financial advice.

What are the main risks for investors in 2228.HK stock?

Main risks include high price-to-sales multiples, negative free cash flow per share, long receivables days, and execution risk for commercial deals. Monitor earnings and partnership updates.

What price targets and upside does the Meyka forecast show for 2228.HK stock?

Meyka AI's model projects **HK$13.19** for the quarter and **HK$10.73** for the year. Quarterly implies **+17.24%** upside, yearly implies **-4.62%** downside. Forecasts are not guarantees.

HK Stocks

XtalPi 2228.HK HK$11.25 at HKSE close 16 Feb 2026: AI outlook vs valuation

ByHuzaifa Zahoor February 16, 2026February 16, 2026

The 2228.HK stock closed at HK$11.25 on the HKSE on 16 Feb 2026 after a day high at HK$11.25. Investors are watching XtalPi Holdings Ltd (2228.HK) for its AI-driven drug discovery tools and automation services in China and overseas. The share trades near its 50-day average of HK$11.03 and sits below a year high of HK$15.12. This report links the latest price action to fundamentals, technicals, and model forecasts. We outline valuation, Meyka AI grade, and near-term targets for Hong Kong traders.